Reduced serum levels of GLP-1 were found among patients with constipation caused by IBS and in animal models exanetide-4, GLP-1 agonist, reduced sensitivity to visceral pain and stress-related defecation [50,51]. The gene discussed is GCG; the disease is irritable bowel syndrome.